Pharmaceutical Biotechnology : Drug Discovery and Clinical Applications / Oliver Kayser, Heribert Warzecha
This second edition of a very successful book is thoroughly updated with existing chapters completely rewritten while the content has more than doubled from 16 to 36 chapters. As with the first edition, the focus is on industrial pharmaceutical research, written by a team of industry experts from around the world, while quality and safety management, drug approval and regulation, patenting issues, and biotechnology fundamentals are also covered. In addition, this new edition now not only includes biotech drug development but also the use of biopharmaceuticals in diagnostics and vaccinations. With a foreword by Robert Langer, Kenneth J Germeshausen Professor of Chemical and Biomedical Engineering at MIT and member of the National Academy of Engineering and the National Academy of Sciences..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
Weinheim: Wiley-VCH ; 2012 |
| Ausgabe: |
2. vollst. überarb. u. stark erw. Auflage |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kayser, Oliver [Mitwirkende/r] |
|---|
| Links: |
nbn-resolving.org [lizenzpflichtig] |
|---|
| ISBN: |
|---|
| Umfang: |
1 Online-Ressource (676 S.) ; Illustrationen |
|---|
| Weitere IDs: |
9783527651252 urn:nbn:de:bsz:31-epflicht-1070087 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
1672056268 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 1672056268 | ||
| 003 | DE-627 | ||
| 005 | 20220919013453.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190825s2012 xx |||||o 00| ||eng c | ||
| 020 | |a 352765125X |c EPUB |9 3-527-65125-X | ||
| 020 | |a 9783527651252 |c EPUB |9 978-3-527-65125-2 | ||
| 024 | 3 | |a 9783527651252 | |
| 024 | 7 | |a urn:nbn:de:bsz:31-epflicht-1070087 |2 urn | |
| 035 | |a (DE-627)1672056268 | ||
| 035 | |a (DE-599)KEP045132585 | ||
| 035 | |a (EPF35)9d215228a5194730a3dc10e73c10ebad | ||
| 035 | |a (EBP)045132585 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 072 | 7 | |a 9672 |2 wsb | |
| 100 | 1 | |a Kayser, Oliver |e mitwirkender |4 ctb | |
| 245 | 1 | 0 | |a Pharmaceutical Biotechnology |b Drug Discovery and Clinical Applications |c Oliver Kayser, Heribert Warzecha |
| 250 | |a 2. vollst. überarb. u. stark erw. Auflage | ||
| 264 | 1 | |a Weinheim |b Wiley-VCH |c 2012 | |
| 300 | |a 1 Online-Ressource (676 S.) |b Illustrationen | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a This second edition of a very successful book is thoroughly updated with existing chapters completely rewritten while the content has more than doubled from 16 to 36 chapters. As with the first edition, the focus is on industrial pharmaceutical research, written by a team of industry experts from around the world, while quality and safety management, drug approval and regulation, patenting issues, and biotechnology fundamentals are also covered. In addition, this new edition now not only includes biotech drug development but also the use of biopharmaceuticals in diagnostics and vaccinations. With a foreword by Robert Langer, Kenneth J Germeshausen Professor of Chemical and Biomedical Engineering at MIT and member of the National Academy of Engineering and the National Academy of Sciences. | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |f PEBW |k DE-576 |2 pdager |5 DE-31 | |
| 650 | 0 | |a Pharmazeutische u. Medizinische Chemie | |
| 650 | 0 | |a Biotechnologie i. d. Biowissenschaften | |
| 650 | 0 | |a Pharmakologie u. Pharmazeutische Medizin | |
| 650 | 4 | |a Biotechnologie | |
| 650 | 4 | |a Biotechnologie i. d. Biowissenschaften | |
| 650 | 4 | |a Biotechnology | |
| 650 | 4 | |a Biowissenschaften | |
| 650 | 4 | |a Chemie | |
| 650 | 4 | |a Chemistry | |
| 650 | 4 | |a Life Sciences | |
| 650 | 4 | |a Medical Science | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Pharmaceutical & Medicinal Chemistry | |
| 650 | 4 | |a Pharmacology & Pharmaceutical Medicine | |
| 650 | 4 | |a Pharmakologie u. Pharmazeutische Medizin | |
| 650 | 4 | |a Pharmazeutische Technologie | |
| 650 | 4 | |a Pharmazeutische u. Medizinische Chemie | |
| 650 | 4 | |a Pharmazeutische u. Medizinische Chemie | |
| 650 | 4 | |a Biotechnologie i. d. Biowissenschaften | |
| 650 | 4 | |a Pharmakologie u. Pharmazeutische Medizin | |
| 700 | 1 | |a Kayser, Oliver |e herausgeberin |4 edt | |
| 700 | 1 | |a Warzecha, Heribert |e herausgeberin |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783527329946 |
| 856 | 4 | 0 | |u http://nbn-resolving.org/urn:nbn:de:bsz:31-epflicht-1070087 |m X:EPF |q application/epub+zip |x Resolving-System |z lizenzpflichtig |
| 856 | 4 | 2 | |u https://cdn.libreka.de/cover/32094ced-888c-4d8e-8813-83880110c043/m |x Verlag |3 Cover |
| 912 | |a EPF-35-WILEY |b 2018 | ||
| 912 | |a EPF-BW-GESAMT | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a ISIL_DE-31 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 951 | |a BO | ||
| 980 | |2 2018 |1 01 |x DE-31 |b 3508785300 |c 00 |f --%%-- |d --%%-- |e n |j n |k Der Zugriff ist nur an ausgewählten Rechnern in der Badischen Landesbibliothek möglich. |y l01 |z 25-08-19 | ||
| 981 | |2 2018 |1 01 |x DE-31 |r http://nbn-resolving.org/urn:nbn:de:bsz:31-epflicht-1070087 | ||